LivaNova (LIVN) Gross Profit Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.52% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.76% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.41% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.59% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.74% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.30% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 27.39% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -1.74% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.72% |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 12.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.71% |
| Dec 31, 2025 | 11.85% |
| Sep 30, 2025 | 10.78% |
| Jun 30, 2025 | 11.22% |
| Mar 31, 2025 | 6.42% |
| Dec 31, 2024 | 22.68% |
| Sep 30, 2024 | 9.53% |
| Jun 30, 2024 | 4.72% |
| Mar 31, 2024 | 16.73% |
| Dec 31, 2023 | -4.78% |
| Sep 30, 2023 | 18.07% |
| Jun 30, 2023 | 11.31% |
| Mar 31, 2023 | 3.35% |
| Dec 31, 2022 | -8.99% |
| Sep 30, 2022 | 1.34% |
| Jun 30, 2022 | 7.01% |
| Mar 31, 2022 | 3.08% |
| Dec 31, 2021 | 20.82% |
| Sep 30, 2021 | 14.28% |
| Jun 30, 2021 | 49.85% |
| Mar 31, 2021 | -1.15% |
| Dec 31, 2020 | -3.28% |
| Sep 30, 2020 | -19.12% |
| Jun 30, 2020 | -43.15% |
| Mar 31, 2020 | -0.74% |
| Dec 31, 2019 | -16.46% |
| Sep 30, 2019 | 4.67% |
| Jun 30, 2019 | 4.26% |
| Mar 31, 2019 | 2.75% |
| Dec 31, 2018 | 20.04% |
| Sep 30, 2018 | 7.72% |
| Jun 30, 2018 | 14.03% |
| Mar 31, 2018 | 9.78% |
| Dec 31, 2017 | 37.20% |
| Sep 30, 2017 | 5.17% |
| Jun 30, 2017 | 14.58% |
| Mar 31, 2017 | 12.08% |
| Oct 18, 2015 | -13.00% |
| Apr 24, 2015 | 0.00% |